This session will explain why companies should pay for their employees' psychedelic therapy and how this revolutionary approach is the future of mental healthcare. The panel will delve into the crippling impact of mental health issues on the economy and demonstrate how employer-funded psychedelic therapy can make these treatments more accessible, affordable, and normalized. This session uniquely addresses the equity crisis in the psychedelic ecosystem, focusing on solutions to make these therapies accessible and affordable for those who cannot pay thousands for retreats abroad.